Literature DB >> 7812618

Binding and growth-inhibitory effect of heparin and oligo-heparin (2kDa) in Balb/c 3T3 cells: lack of effect on PDGF- or serum-induced inositol lipid turnover.

S Cavari1, G Fiorelli, S Vannucchi.   

Abstract

1. The ability of heparins (bovine heparin sm 1026, Av. mol. wt. 36.9 kDa and bovine heparin EP 756, Av. mol. wt. 12.9 kDa) and heparin fractions of different molecular weights (low molecular weight heparin, LMW 2123/OP, Av. mol. wt. 4.5 kDa and oligo-heparin, Av. mol. wt. 2 kDa) to inhibit the proliferation and signalling of Balb/c 3T3 fibroblasts was investigated. 2. Heparin and heparin fractions of 4.5 and 2 kDa significantly inhibited DNA synthesis as monitored by [2H]-thymidine incorporation. 3. 3H-labelled heparin fractions of 4.5 and 2 kDa were prepared by gel-chromatography fractionation on Sephadex G-75 of an 3H-labelled commercial heparin after treatment with heparinase. 4. The binding of unfractionated and oligo-heparin of 2 kDa to Balb/c 3T3 fibroblasts was studied; we determined the specificity of heparin and oligo-heparin binding to the cells by means of displacement of bound 3H-labelled compound in response to increasing concentrations of unlabelled compounds. Scatchard analysis of binding data obtained using [3H]-heparin as ligand revealed the presence of a single class of high affinity binding sites (Kd = 28 nM) for heparin. Scatchard analysis of binding data obtained using [3H]-oligo-heparin as ligand revealed the presence of a single class of low affinity binding sites (Kd = 3.2 microM) for oligo-heparin. 5. In addition heparin displaced [3H]-oligo-heparin at a concentration of approximately 100 fold of the Kd determined in displacement studies. Furthermore, oligo-heparin significantly displaced [3H]-heparin at a concentration of approximately 10 fold of the Kd determined by displacement studies. 6. Both heparin and oligo-heparin exert their inhibitory effects on Balb/c 3T3 DNA synthesis stimulated by PDGF or serum. However these molecules did not affect the inositol lipid turnover triggered by PDGF at a concentration which did not produce maximal response. The increase of inositol phosphate metabolism produced by 20% serum was also unaffected by heparin. This concentration of serum elicited a response comparable to that induced by a submaximal concentration of PDGF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7812618      PMCID: PMC1510037          DOI: 10.1111/j.1476-5381.1994.tb16202.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.

Authors:  R L Jackson; S J Busch; A D Cardin
Journal:  Physiol Rev       Date:  1991-04       Impact factor: 37.312

2.  Low molecular weight heparins (5 kDa) and oligoheparins (2 kDa) produced by gel permeation enrichment or radical process: comparison of structures and physicochemical and biological properties.

Authors:  N Volpi; G Mascellani; P Bianchini
Journal:  Anal Biochem       Date:  1992-01       Impact factor: 3.365

3.  Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells.

Authors:  L A Pukac; J J Castellot; T C Wright; B L Caleb; M J Karnovsky
Journal:  Cell Regul       Date:  1990-04

4.  Heparin inhibits A431 cell growth independently of serum and EGF mitogenic signalling.

Authors:  S Vannucchi; F Pasquali; V P Chiarugi; M Ruggiero
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

5.  A general method for the detection and mapping of submicrogram quantities of glycosaminoglycan oligosaccharides on polyacrylamide gels by sequential staining with azure A and ammoniacal silver.

Authors:  M Lyon; J T Gallagher
Journal:  Anal Biochem       Date:  1990-02-15       Impact factor: 3.365

6.  Effect of heparin on proliferation and signalling in BC3H-1 muscle cells. Evidence for specific binding sites.

Authors:  S Vannucchi; F Pasquali; G Fiorelli; P Bianchini; M Ruggiero
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

7.  Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells.

Authors:  L A Pukac; M E Ottlinger; M J Karnovsky
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

8.  Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo.

Authors:  L A Pukac; G M Hirsch; J C Lormeau; M Petitou; J Choay; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

9.  Heparin inhibits the attachment and growth of Balb/c-3T3 fibroblasts on collagen substrata.

Authors:  J D San Antonio; A D Lander; T C Wright; M J Karnovsky
Journal:  J Cell Physiol       Date:  1992-01       Impact factor: 6.384

10.  The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts.

Authors:  A V Ferrao; R M Mason
Journal:  Biochim Biophys Acta       Date:  1993-01-22
View more
  1 in total

1.  Transdermal delivery of heparin using pulsed current iontophoresis.

Authors:  Stefania Pacini; Tiziana Punzi; Massimo Gulisano; Fabiola Cecchi; Simonetta Vannucchi; Marco Ruggiero
Journal:  Pharm Res       Date:  2006-12-21       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.